Construction of a Predictive Model of Gangrenous Cholecystitis Based on Machine Learning
A Real-world Study of Predictive Models of Gangrenous Cholecystitis Based on Machine Learning
1 other identifier
observational
1,006
1 country
1
Brief Summary
Gangrenous cholecystitis is the most common complication of acute cholecystitis. There is no research using machine learning models to construct predictive diagnostic models for gangrenous cholecystitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 2, 2024
CompletedFirst Submitted
Initial submission to the registry
April 29, 2024
CompletedFirst Posted
Study publicly available on registry
May 3, 2024
CompletedMay 3, 2024
May 1, 2024
3 months
April 29, 2024
May 1, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
pathological diagnosis of patients with cholecystectomy
Check the patient's pathological report and whether the pathological description contains phenomena such as full layer ischemic necrosis and ulceration of the gallbladder wall. Diagnose as gangrenous cholecystitis or non-gangrenous cholecystitis.
30 days
The predictive performance of diagnostic prediction models
The predictive diagnosis was obtained by the model and each predictive variable, and the metric (Accuracy, Recall, Precision, F1score) of the model was obtained by comparing with the actual pathological diagnosis.
through study completion, an average of 4 months
Secondary Outcomes (6)
WBC value (10*9/L)
through study completion, an average of 4 months
Alanine transaminase value (ALT, U/L)
through study completion, an average of 4 months
D-dimer value
through study completion, an average of 4 months
Fibrinogen value (g/L)
through study completion, an average of 4 months
BMI (Kg/m2)
through study completion, an average of 4 months
- +1 more secondary outcomes
Study Arms (2)
Gangrenous cholecystitis
Defined based on intraoperative findings or pathological diagnosis
Non-gangrenous cholecystitis
Non-gangrenous cholecystitis, such as chronic cholecystitis, acute cholecystitis, acute attack of chronic cholecystitis
Interventions
Eligibility Criteria
The patients admitted to the Second Hospital of Dalian Medical University who were diagnosed with cholecystitis through ICD-9 code recognition and underwent cholecystectomy from January 2015 to May 2023
You may qualify if:
- patients diagnosed with acute cholecystitis or acute exacerbation of chronic cholecystitis in our hospital and receiving complete clinical treatment in our hospital;
- performing cholecystectomy;
- having complete and searchable clinical data, such as patient's age, surgical records, and hospitalization days.
You may not qualify if:
- previous diagnosis of chronic cholecystitis, this time for elective surgical treatment;
- previous diagnosis of acute cholecystitis, ultrasound-guided cholecystectomy after elective laparoscopic cholecystectomy;
- concomitant with other acute biliary and pancreatic system-related diseases, such as obstructive jaundice caused by choledochal stones, acute cholangitis, acute pancreatitis, etc.;
- exclude patients who combined with other surgery patients such as choledochotomy and lithotripsy, choledochoscopic exploration and lithotripsy, bile-intestinal anastomosis, appendectomy, etc;
- those with incomplete data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Second Hospital of Dalian Medical University
Dalian, Liaoning, 116023, China
Related Publications (3)
Wu B, Buddensick TJ, Ferdosi H, Narducci DM, Sautter A, Setiawan L, Shaukat H, Siddique M, Sulkowski GN, Kamangar F, Kowdley GC, Cunningham SC. Predicting gangrenous cholecystitis. HPB (Oxford). 2014 Sep;16(9):801-6. doi: 10.1111/hpb.12226. Epub 2014 Mar 17.
PMID: 24635779BACKGROUNDYacoub WN, Petrosyan M, Sehgal I, Ma Y, Chandrasoma P, Mason RJ. Prediction of patients with acute cholecystitis requiring emergent cholecystectomy: a simple score. Gastroenterol Res Pract. 2010;2010:901739. doi: 10.1155/2010/901739. Epub 2010 Jun 8.
PMID: 20631896BACKGROUNDBorzellino G, Sauerland S, Minicozzi AM, Verlato G, Di Pietrantonj C, de Manzoni G, Cordiano C. Laparoscopic cholecystectomy for severe acute cholecystitis. A meta-analysis of results. Surg Endosc. 2008 Jan;22(1):8-15. doi: 10.1007/s00464-007-9511-6. Epub 2007 Aug 18.
PMID: 17704863BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident physician
Study Record Dates
First Submitted
April 29, 2024
First Posted
May 3, 2024
Study Start
December 1, 2023
Primary Completion
March 1, 2024
Study Completion
March 2, 2024
Last Updated
May 3, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share
The data where our results derived from were from the Second Hospital of Dalian Medical University. The original data were not publicly available and could only be shared with the permission of the Ethics Committee of the Second Hospital of Dalian Medical University.